Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression

International Journal of Oncology

Volumn 28, Issue 6, 2006, Pages 1369-1374

  Miyazaki, Noriyuki ^a   Abe, Yoshiyuki ^a   Oida, Yasuhisa ^a   Suemizu, Hiroshi ^b   Nishi, Masatake ^a   Yamazaki, Hitoshi ^a   Iwasaki, Masayuki ^a   Inoue, Hiroshi ^a   Ueyama, Yoshito ^a,b   Nakamura, Masato ^a,b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

E cadherin; Metastasis; Prognosis; Pulmonary adenocarcinoma; S100A4

Indexed keywords

CADHERIN; PROTEIN S 100; S100A4 PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METASTASIS; MORTALITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; CADHERINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; S100 PROTEINS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33747109199     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.6.1369     Document Type: Article

References (32)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
2. Wheelock MJ and Jensen PJ: Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol 117: 415-425, 1992.
3. Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339, 1998.
4. Kimura K, Endo Y, Yonemura Y, Heizmann CW, Schäfer BW, Watanabe Y and Sasaki T: Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 16: 1125-1131, 2000.
5. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
6. Behrens J, Mareel MM, van Roy FM and Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasion properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989.
7. Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, Schafer BW and Sasaki T: Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242, 2000.
8. Kohya N, Kitajima Y, Jiao W and Miyazaki K: Effects of E-cadherin transfection on gene expression of a gall bladder carcinoma cell line: repression of MTS1/S100A4 gene expression. Int J Cancer 104: 44-53, 2003.
9. Schafer BW and Heizmann CW: The S100 family of EF-hand calcium binding proteins: functions and pathology. Trends Biochem Sci 21: 134-140, 1996.
10. Watanabe Y, Kobayashi R, Ishikawa T and Hidaka H: Isolation and characterization of a calcium-binding protein derived from mRNA termed p9Ka, pEL-98, 18A2, or 42A by the newly synthesized vasorelaxant W-66 affinity chromatography. Arch Biochem Biophys 292: 563-569, 1992.
11. 2+-binding protein family. Genes Dev 3: 1086-1093, 1989.
12. Mazzucchelli L: Protein S100A4: too long overlooked by pathologists? Am J Pathol 160: 7-13, 2002.
13. Davies BR, Davies MP, Gibbs FE, Barraclough R and Rudland PS: Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8: 999-1008, 1993.
14. Grigorian M, Ambertsumian N, Lykkesfeldt AE, Bastholm L, Elling F, Georgiev G and Lukanidin E: Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer 67: 831-841, 1996.
15. Davies MPA, Rudland PS, Robertson L, Parry E, Jolicoeur P and Barraclough R: Expression of calcium binding protein S100A4 in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13: 1631-1637, 1996.
16. Lloyd BH, Platt-Higgins A, Rudland PS and Barraclough R: Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene 17: 465-473, 1998.
17. Barraclough R: Calcium binding protein S100A4 in health and disease. Biochim Biophys Acta 1448: 190-199, 1998.
18. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H and Wasielewski RV: Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123: 1478-1484, 2002.
19. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L and Barraclough R: Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603, 2000. (Pubitemid 30183430)
20. Nakamura T, Ajiki T, Murao S, Kamigaki T, Maeda S, Ku Y and Kuroda Y: Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 20: 937-941, 2002.
21. Travis WD, Corrin B, Shimosato Y and Brambilla E: in collaboration with Sobin LH and Pathologists from 14 countries. World Health Organization International Histological Classification of Tumors. Histologic typing of lung and pleural tumours. 3rd edition. Springer, Berlin, pp34-40, 1999.
22. Abe Y, Nakamura M, Ohnishi Y, Inaba M, Ueyama Y and Tamaoki N: Multidrug resistance gene (MDR1) expression in human tumor xenografts. Int J Oncol 5: 1285-1292, 1994. (Pubitemid 24357472)
23. Abe Y, Ohnishi Y, Yoshimura M, et al: P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br J Cancer 74: 1929-1934, 1996.
24. Fujimori S, Abe Y, Nishi M, et al: The subunits of glutamate cysteine ligase (GCL) enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo. Int J Oncol 25: 413-418, 2004.
25. Hamamoto A, Abe Y, Nishi M, et al: Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts. Int J Oncol 26: 891-896, 2005.
26. Nishi M, Abe Y, Tomii, Y, Tsukamoto H, Kijima H, Yamazaki H, Ohnishi Y, Iwasaki M, Inoue H, Ueyama Y and Nakamura M: Cell binding isoforms of vascular endothelial growth factor-A (VEGF189) contribute blood flow-distant metastasis of pulmonary adenocarcinoma. Int J Oncol 26: 1517-1524, 2005.
27. Keirsebilck AB, Bonne S, Bruyneel E, Vermassen P, Lukanidin E, Mareel M and van Roy F: E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. Cancer Res 58: 4587-4591, 1998.
28. Anderson K, Nesland JM, Holm R, Flørenes VA, Fodstad Ø and Mælandsmo GM: Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma. Mod Pathol 17: 990-997, 2004.
29. Moriyama-Kita M, Endo Y, Yoneyama Y, Heizmann CW, Schäfer BW, Sasaki T and Yamamoto E: Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma. Oral Oncol 40: 496-500, 2004.
30. Takenaga A, Nakamura Y, Endo H and Sakiyama S: Involvement of S100 related calcium binding protein pEL98 (or mts1) in cell motility and tumor cell invasion. Jpn J Cancer Res 85: 831-839, 1994.
31. Ford HL, Salim MN, Chakravarty R, Aluiddin V and Zain SB: Expression of mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene 11: 2067-2075, 1995.
32. Grigorian MS, Tulchinsky EM, Zain S, Ebralidze AK, Kramerov DA, Kriajevska MV, Georgiev GP and Lukanidin EM: The mts1 gene and control of tumor metastasis. Gene 135: 229-238, 1993.